We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MORN icon
3851
Morningstar
MORN
$7.41B
$19K ﹤0.01%
79
-1,413
-95% -$356K
NAII icon
3852
Natural Alternatives International
NAII
$13.2M
$19K ﹤0.01%
1,818
+1,459
+406% +$14.8K
NZF icon
3853
Nuveen Municipal Credit Income Fund
NZF
$2.42B
$19K ﹤0.01%
+1,492
New +$19.4K
OIH icon
3854
VanEck Oil Services ETF
OIH
$1.95B
$19K ﹤0.01%
82
-10,645
-99% -$2.92M
ORLA
3855
DELISTED
Orla Mining
ORLA
$19K ﹤0.01%
7,052
+915
+15% +$3.76K
PAHC icon
3856
Phibro Animal Health
PAHC
$1.37B
$19K ﹤0.01%
1,014
+643
+173% +$12.2K
SENEB
3857
Seneca Foods Class B
SENEB
$1.28B
$19K ﹤0.01%
352
-568
-62% -$31.5K
SPRO icon
3858
Spero Therapeutics
SPRO
$71.8M
$19K ﹤0.01%
25,077
+12,654
+102% +$36.8K
STEL
3859
DELISTED
Stellar Bancorp
STEL
$19K ﹤0.01%
722
+574
+388% +$16.2K
TIGR
3860
UP Fintech Holding
TIGR
$833M
$19K ﹤0.01%
4,071
-6,705
-62% -$28.5K
STLN
3861
Starling Oncology, Inc. Common Stock
STLN
$644M
$19K ﹤0.01%
3,688
+2,873
+353% +$20.9K
UAN icon
3862
CVR Partners
UAN
$1.26B
$19K ﹤0.01%
+193
New +$25.9K
VERA icon
3863
Vera Therapeutics
VERA
$2.08B
$19K ﹤0.01%
1,430
+1,203
+530% +$21K
VTOL icon
3864
Bristow Group
VTOL
$1.36B
$19K ﹤0.01%
820
+659
+409% +$19.4K
WTBA icon
3865
West Bancorporation
WTBA
$511M
$19K ﹤0.01%
790
-427
-35% -$10.6K
INVX
3866
Innovex International
INVX
$2.15B
$19K ﹤0.01%
748
-7,251
-91% -$221K
LGF.A
3867
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$19K ﹤0.01%
2,043
+1,265
+163% +$15.4K
OMGA
3868
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$19K ﹤0.01%
5,210
+3,537
+211% +$13.2K
CHUY
3869
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$19K ﹤0.01%
976
+618
+173% +$14.2K
PRST
3870
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$19K ﹤0.01%
1,846
+1,029
+126% +$10.5K
SOLO
3871
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$19K ﹤0.01%
+14,114
New +$23.3K
CHS
3872
DELISTED
Chicos FAS, Inc.
CHS
$19K ﹤0.01%
3,938
-40,759
-91% -$206K
TCRR
3873
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$19K ﹤0.01%
6,727
-2,969
-31% -$7.33K
TA
3874
DELISTED
TravelCenters of America LLC
TA
$19K ﹤0.01%
545
-4,898
-90% -$182K
IMGO
3875
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$19K ﹤0.01%
1,393
+863
+163% +$13.7K
153 154
155
156 157

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.